Micro-Dose MP-101 Preserves Motor & Muscle Function in ALS Mice With Potential Functional Recovery After Disease Onset
Time: 11:40 am
day: CONFERENCE DAY ONE
Details:
- Micro-dose MP-101 delays ALS disease onset and progression in hSOD1G93A mice
- ALS mice treated with MP-101 exhibit improved motor function, muscle innervation and muscle contractile function
- MP-101 treatment in hSOD1G93A from disease onset promotes recovery in mouse running ability
